Gulf Canadian Company for Arab Real Estate Investment (EGX:CCRS)

CTI BioPharma Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	247	235	91	72	59	253
Market Cap Growth	164.97%	158.53%	26.25%	21.62%	-76.64%	413.06%
Enterprise Value	241	229	90	71	59	252
Last Close Price	4.11	3.92	1.51	1.20	0.99	4.22
PE Ratio	-	-	41.58	-	-	-
PS Ratio	-	-	13.86	36.00	-	-
PB Ratio	8.60	8.15	3.07	2.63	2.10	8.30
P/TBV Ratio	8.60	8.15	3.07	2.63	2.10	8.30
P/FCF Ratio	-	69.37	208.25	107.86	-	-
P/OCF Ratio	-	68.89	208.25	107.86	-	-
EV/Sales Ratio	-	-	13.79	35.34	-	-
EV/EBITDA Ratio	-	-	41.44	-	-	-
EV/EBIT Ratio	-	-	42.18	-	-	-
EV/FCF Ratio	-172.56	67.52	207.21	105.89	-	-
Asset Turnover	-	-	0.22	0.07	-	-
Inventory Turnover	0.00	0.00	0.16	0.07	-	-
Quick Ratio	5.24	5.40	6.38	3.99	3.36	1.91
Current Ratio	12.67	12.98	15.04	14.69	13.96	30.78
Return on Equity (ROE)	-2.31%	-2.54%	7.67%	-2.69%	-8.14%	-3.16%
Return on Assets (ROA)	-3.76%	-3.65%	4.39%	-1.62%	-2.14%	-1.33%
Return on Capital (ROIC)	-4.06%	-3.93%	4.70%	-1.74%	-3.01%	-2.25%
Return on Capital Employed (ROCE)	-	-	7.20%	-	-	-
Earnings Yield	-0.27%	-0.32%	2.40%	-1.04%	-4.04%	-0.39%
FCF Yield	-0.57%	1.44%	0.48%	0.93%	-1.59%	-0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.